You are here

  • Home
  • Archive
  • Volume 74, Issue 2
  • Discontinuation of adalimumab after achieving remission in patients with established rheumatoid arthritis: 1-year outcome of the HONOR study

Article metrics

Article menu

This article has a correction. Please see:

Clinical and epidemiological research
Extended report
Discontinuation of adalimumab after achieving remission in patients with established rheumatoid arthritis: 1-year outcome of the HONOR study

 

Online download statistics by month:

Online download statistics by month: November 2013 to December 2019

AbstractFullPdf
Nov 201360063145
Dec 2013900338362
Jan 201421879103
Feb 2014626771
Mar 2014666284
Apr 2014326548
May 2014446464
Jun 2014396969
Jul 2014356570
Aug 2014263951
Sep 2014265154
Oct 2014295267
Nov 2014225050
Dec 2014215042
Jan 20151572125338
Feb 201560262209
Mar 201528597189
Apr 201516859148
May 20151105466
Jun 20151065252
Jul 2015835170
Aug 2015633751
Sep 2015953243
Oct 2015642220
Nov 2015543154
Dec 2015563129
Jan 2016965361
Feb 2016543747
Mar 2016924253
Apr 2016803555
May 2016523353
Jun 2016462940
Jul 2016553245
Aug 2016574245
Sep 2016602640
Oct 2016514649
Nov 2016493137
Dec 2016383430
Jan 2017573240
Feb 2017142223
Mar 2017155130
Apr 201766236
May 201785324
Jun 2017235729
Jul 2017625335
Aug 2017655959
Sep 2017786821
Oct 2017715522
Nov 2017946924
Dec 2017473924
Jan 2018938445
Feb 2018534315
Mar 2018554716
Apr 2018854322
May 2018604011
Jun 2018725416
Jul 2018746022
Aug 2018766240
Sep 2018554519
Oct 2018613929
Nov 2018694347
Dec 2018575122
Jan 2019624930
Feb 2019605321
Mar 2019915924
Apr 2019726029
May 2019574826
Jun 2019585010
Jul 2019695920
Aug 2019645825
Sep 2019585323
Oct 2019967729
Nov 2019795532
Dec 2019796725
Total830341264069